Aurobindo Pharma USA, Inc.
Aurobindo Pharma USA, Inc., a subsidiary of Aurobindo Pharma Limited, is a prominent player in the pharmaceutical industry, headquartered in the United States. Established in 2003, the company has rapidly expanded its operations across key regions, including North America and Europe, focusing on the development and manufacturing of generic and specialty pharmaceuticals. With a diverse portfolio that includes injectables, oral solids, and complex formulations, Aurobindo Pharma USA stands out for its commitment to quality and innovation. The company has achieved significant milestones, including numerous FDA approvals, which solidify its market position as a trusted provider of affordable medications. Aurobindo's dedication to research and development ensures that it remains at the forefront of the pharmaceutical landscape, delivering unique solutions that meet the evolving needs of healthcare providers and patients alike.
DitchCarbon Score
How does Aurobindo Pharma USA, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aurobindo Pharma USA, Inc.'s score of 27 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aurobindo Pharma USA, Inc.'s reported carbon emissions
Aurobindo Pharma USA, Inc. currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Aurobindo Pharma may be engaging in industry-standard practices to address climate change, but specific details regarding their emissions or climate commitments are not provided.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aurobindo Pharma USA, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
